Why Quest Diagnostics (DGX) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks·3d ago
More News
New Study Demonstrates Accuracy of Two Quest AD-Detect Tests for Alzheimer's Disease Diagnosis
New Study Demonstrates Accuracy of Two Quest AD-Detect Tests for Alzheimer's Disease Diagnosis New Study Demonstrates Accuracy of Two Quest AD-Detect Tests for Alzheimer's Disease Diagnosis PR...
PR Newswire·3d ago
Here's Why Quest Diagnostics (DGX) is a Strong Growth Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks·8d ago
Quest Diagnostics Stock Up on Q3 Earnings & Revenue Beat, Margins Rise
DGX posts a strong Q3 with revenues and EPS beating estimates, higher margins and an upbeat full-year outlook.
Zacks·9d ago
Quest Diagnostics (DGX) Surpasses Q3 Earnings and Revenue Estimates
Quest Diagnostics (DGX) delivered earnings and revenue surprises of +3.59% and +3.45%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·9d ago
Quest Diagnostics Reports Third Quarter 2025 Financial Results; Raises Guidance for Full Year 2025
Quest Diagnostics Reports Third Quarter 2025 Financial Results; Raises Guidance for Full Year 2025 Quest Diagnostics Reports Third Quarter 2025 Financial Results; Raises Guidance for Full Year 2025...
PR Newswire·9d ago
Tempus AI Fuels Growth Through Strategic Biotech Collaborations
TEM expands its AI-driven growth with new collaborations in oncology, neurogenomics, and diagnostic innovation.
Zacks·13d ago
Will Quest Diagnostics (DGX) Beat Estimates Again in Its Next Earnings Report?
Quest Diagnostics (DGX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Zacks·16d ago
Quest Diagnostics (DGX) Reports Next Week: Wall Street Expects Earnings Growth
Quest Diagnostics (DGX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·16d ago
Here's How Quest Diagnostics Is Placed Ahead of Q3 Earnings
DGX is poised for solid Q3 2025 results, backed by strong DIS growth, strategic M&A and robust test demand across key health segments.